United Therapeutics

UTHRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$21.149 B

$493.10 -0.31%

Close of 21 Sept 2026

Revenue

$3.18B

#887 by revenue

Earnings

$1.33B

#310 by earnings

Shares outstanding

42,890,692

Latest filing cover page

P/E ratio

15.8

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#21Roivant SciencesROIV$28.2B
#22InsmedINSM$26.4B
#23United TherapeuticsUTHR$21.1B
#24ViatrisVTRS$19.6B
#25Jazz PharmaceuticalsJAZZ$15.7B

What if United Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$705,842.05

Per share 1,431× higher

Bitcoin $1.72T

$40,097.36

Per share 81.3× higher

Nvidia $5.48T

$127,763.34

Per share 259× higher

Or at a round number

$50.0B $100.0B $200.0B $500.0B

Where these numbers come from

Share counts and financials for United Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.